Non-oral formulations of triptans and their use in acute migraine

The introduction of triptans (5-HT (1B/1D) agonists) into clinical practice has expanded the therapeutic options for doctors treating migraine sufferers. The triptans are available in several different formulations such as conventional oral tablets, orally disintegrating wafers, subcutaneous injecti...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Current pain and headache reports 2005-06, Vol.9 (3), p.206-212
1. Verfasser:	Dahlöf, Carl G H
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Chemistry, Pharmaceutical Humans Migraine Migraine Disorders - drug therapy Patient Satisfaction Tryptamines - administration & dosage Tryptamines - adverse effects Tryptamines - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!